Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

Published:2019-08-27 Issue:8 Volume:322 Page:764
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Arbour Kathryn C.¹,Riely Gregory J.¹

Affiliation:

1. Thoracic Oncology Service, Division of Solid Tumor, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/article-pdf/322/8/764/17823349/jama_arbour_2019_rv_190008.pdf

Reference85 articles.

1. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database.;Govindan;J Clin Oncol,2006

2. Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies.;Jordan;Cancer Discov,2017

3. Cancer statistics, 2019.;Siegel;CA Cancer J Clin,2019

4. Lung cancer in never smokers—a review.;Couraud;Eur J Cancer,2012

5. Screening for lung cancer: US Preventive Services Task Force recommendation statement.;Moyer;Ann Intern Med,2014

Cited by 783 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the CD44-targeted delivery of self-assembled hyaluronan nanogel to reverse the antagonism between Cisplatin and Gefitinib in NSCLC cancer therapy;Carbohydrate Polymers;2024-11

2. A Novel Tryptanthrin Derivative D6 Induces Apoptosis and DNA Damage in Non-small-cell Lung Cancer Cells Through Regulating the EGFR Pathway;Anti-Cancer Agents in Medicinal Chemistry;2024-10

3. Targeting non-coding RNAs to overcome osimertinib resistance in EGFR-mutated non-small cell lung cancer;Frontiers in Oncology;2024-09-11

4. The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes;World Journal of Surgical Oncology;2024-09-05

5. Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1;Advanced Science;2024-09-04